"ALA-CART improves the ability of CAR-T cells to detect and attack resistant cancer cells more effectively. This could lead to longer lasting results, even when other treatments have failed," said ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with Parkinson’s disease and observed promising motor improvements with no ...

Perhaps the most promising use for iPS cells is in the treatment of Parkinson’s disease, a neurodegenerative condition due to the death of dopamine-secreting neurons in the brain.

Induced Pluripotent Stem Cell (iPSC) Industry Trends & Forecasts 2025-2030: From Disease Modeling to Cell Therapy - iPSCs Emerge as Cornerstone of Precision Healthcare - ResearchAndMarkets.com ...

“This trial showed that iPS cell–derived dopaminergic neurons are safe, produce dopamine in the brain, and ameliorate neurological symptoms. I think it is a significant first step,” study ...